Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China

Summary

The mainstay of treatment for atrial fibrillation remains pharmacological;however,catheter ablation has increasingly been used over the last decades. The relative merits of each strategy have not been extensively studied. Our study was designed to determine if catheter ablation is a feasible option as first-line therapy for treating patients with symptomatic AF.

Conditions

• Atrial Fibrillation

Interventions

PROCEDURE

catheter ablation

circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation circumferential pulmonary vein isolation combined left atrial roof ablation circumferential pulmonary vein isolation combined left atrial isthmus ablation circumferential pulmonary vein isolation combined left atrial roof and isthmus ablation circumferential pulmonary vein isolation combined complex fractionated atrial electrograms ablation

DRUG

Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists

Sponsors & Collaborators

• Capital Medical University

  collaborator OTHER

• Peking Union Medical College

  collaborator OTHER

• Guangdong Provincial People's Hospital

  collaborator OTHER

• Nanjing Medical University

  collaborator OTHER

• West China Hospital

  collaborator OTHER

• Dalian Medical University

  collaborator OTHER

• Shanghai Chest Hospital

  collaborator OTHER

• Wuhan University

  lead OTHER

Principal Investigators

• Cong xin Huang, doctor · Renmin Hospital of Wuhan University

Study Design

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-04-30

Primary Completion

2014-12-31

Completion

2015-12-31

Countries

• China

Study Locations